Biotech News
Tempest Announces Partnership for TPST-2003 in Preparation for Planned U.S. Registrational Study in 2026
ir.tempesttx.com2026-05-06 15:17 EST
Cincinnati Children’s Applied Gene and Cell Therapy Center selected to conduct tech transfer, development and IND-enabling manufacturing All activities other than long-term stability testing planned to be complete in Q3 2026 to support potential IND filing in Q4 2026 Selection of tech transfer